Literature DB >> 2234101

The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.

E Schömig1, C L Schönfeld, T Halbrügge, K H Graefe, U Trendelenburg.   

Abstract

After loading of the incubated rat vas deferens with 0.2 mumol/l 3H-noradrenaline (followed by 100 min of wash-out with amine-free solution), the efflux of endogenous and exogenous compounds was determined by HPLC with electrochemical detection and by column chromatography with scintillation counting. Two different types of heterogeneity of labelling were found. The first one is due to the preferential labelling of varicosities close to the surface of the tissue, the second one to the preferential labelling of vesicles close to the surface of loaded varicosities. As diffusion distances within the tissue and within varicosities are then longer for endogenous than for exogenous amine and metabolites, the composition of spontaneous efflux of exogenous compounds differed from that for endogenous compounds. Because of preferential neuronal and vesicular re-uptake of endogenous noradrenaline, the percentage contribution by noradrenaline to overall efflux was: endogenous less than exogenous. While 3H-DOPEG was the predominant exogenous metabolite, DOPEG and MOPEG equally contributed to the "endogenous" efflux. Desipramine abolished the consequences of the first heterogeneity of labelling, i.e., it increased the efflux more for endogenous than for exogenous noradrenaline; moreover it decreased the efflux of 3H-DOPEG, but increased that of 3H-MOPEG. The reserpine-like compound Ro 4-1284, on the other hand, abolished the consequences of the second type of heterogeneity; it reduced the specific activity of "total efflux" (i.e., of the sum of noradrenaline + DOPEG + MOPEG) to the specific activity of the tissue noradrenaline. The degree of heterogeneity of labelling was reduced after inhibition of monoamine oxidase and also when the tissues were loaded with 2 or 20 mumol/l 3H-noradrenaline. It is proposed that the various "compartments" and "pools" of noradrenaline described in the literature reflect the two heterogeneities described here.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2234101     DOI: 10.1007/bf00166959

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.

Authors:  I Azevedo; D Moura; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Uptake of tyramine into synaptic vesicles of the caudate nucleus.

Authors:  H Lentzen; A Philippu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

3.  The effect of hydrocortisone on the sensitivity of the isolated nictitating membrane to catecholamines: Relationship to extraneuronal uptake and metabolism.

Authors:  K H Graefe; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

5.  Dissociation constants and lipophilicity of catecholamines and related compounds.

Authors:  F Mack; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

6.  Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine.

Authors:  L L Iversen; P J Salt; H A Wilson
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

7.  Differential labelling of intraneuronal noradrenaline stores with different concentrations of (-)-3H-noradrenaline.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

8.  Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model.

Authors:  E Schömig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

9.  The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport.

Authors:  A Langeloh; H Bönisch; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

10.  Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress.

Authors:  T Halbrügge; T Gerhardt; J Ludwig; E Heidbreder; K H Graefe
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

View more
  18 in total

1.  Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.

Authors:  I Azevedo; D Moura; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines.

Authors:  D Moura; I Azevedo; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

3.  The influence of the density of adrenergic innervation on the extracellular steady-state concentration gradient for 3H-noradrenaline.

Authors:  E Schömig; I Azevedo; D Moura; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

4.  Carrier-mediated outward transport of dopamine from adrenergic varicosities of the vas deferens of reserpine-pretreated rats.

Authors:  A Langeloh; T Halbrügge; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

Review 5.  Physiology of the vas deferens.

Authors:  W D Steers
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

6.  Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens.

Authors:  I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

7.  Inhibition of purinergic transmission by prostaglandin E1 and E2 in the guinea-pig vas deferens: an electrophysiological study.

Authors:  J A Brock; T C Cunnane
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

8.  Potentiation of potassium-evoked noradrenaline and neuropeptide Y co-release by cardiac energy depletion: role of calcium channels and sodium-proton exchange.

Authors:  M Haass; G Richardt; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

9.  Electrically induced release of endogenous noradrenaline and dopamine from brain slices: pseudo-one-pulse stimulation utilized to study presynaptic autoinhibition.

Authors:  A Thienprasert; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

10.  Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex.

Authors:  J P Finberg; K Pacak; I J Kopin; D S Goldstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.